Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
AHA commentd on the Centers for Medicare & Medicaid Services’ proposed rule for policy and technical changes to the Medicare Advantage program in contract year 2024.
The recent decision to sunset the COVID-19 public health emergency (PHE) is a testament to the progress we have made; however, as we prepare for that transition, we should not revert to care delivery as it was prior to the pandemic. Instead let us build on the lessons we have learned and the…
AHA requests the opportunity to meet with HHS now that the district court in American Hospital Association v. Becerra has remanded the question of how to repay 340B hospitals to the Department of Health and Human Services.
January 31, 2023
April Tabor
Secretary Federal Trade Commission
600 Pennsylvania Avenue NW
Suite CC-5610 (Annex C)
Washington, DC 20580
Re: Notice of Proposed Rulemaking, Federal Trade Commission; Non-Compete Clause Rule; 88 Fed. Reg. 3482 (RIN: 3084-AB74) (January 19, 2023)
Dear Ms. Tabor:
AHA comments on the CMS’ Request for Information on Essential Health Benefits (EHB).
AHA comments on the CMS' proposed Notice of Benefit and Payment Parameters for 2024.
AHA provides feedback to the Senate on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform.
AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform
AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (“Part 2”).
January 27, 2023
Emeka Egwim, PharmD, RPh LCDR
U.S. Public Health Service Director
Office of Pharmacy Affairs
Health Resources and Services Administration 5600 Fishers Lane, 08W05A
Rockville, MD 20857
RE: HRSA 340B Drug Pricing Program; Administrative Dispute Resolution Proposed Rule, HHS Docket…